Tutag Pharmaceuticals

S.J. Tutag & Company, later known as Tutag Pharmaceuticals, was a mid-sized American pharmaceutical firm primarily active during the mid-20th century. Based in Michigan, the company focused on the manufacture and distribution of a broad portfolio of generic and proprietary small molecule drugs, including analgesics, sedatives, and cardiovascular treatments. The company was a notable participant in the U.S. pharmaceutical market until the late 1970s, when it was consolidated into larger entities. Its history is often cited in regulatory contexts regarding the FDA's Drug Efficacy Study Implementation (DESI) program, which evaluated the effectiveness of drugs approved prior to 1962.